ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tirone E. David
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by David, T. E.
Right arrow Articles by Sun, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, T. E.
Right arrow Articles by Sun, Z.

Ann Thorac Surg 1992;54:661-668
© 1992 The Society of Thoracic Surgeons


Articles

Clinical and hemodynamic assesment of the Hancock II bioprosthesis

Tirone E. David, MD*, Susan Armstrong, MSc, Zhao Sun, MA

Division of Cardiovascular Surgery, The Toronto Hospital and University of Toronto, Toronto, Ontario, Canada

* Address reprint requests to Dr David, 200 Elizabeth St, 13EN219, Toronto, Ontario M5G 2C4, Canada.

The Hancock II bioprosthesis was used for heart valve replacement in 614 patients front 1982 to 1990. Aortic valve replacement (AVR) was performed in 376 patients, mitral valve replacement (MVR) in 195, and aortic and mitral valve replacement (DVR) in 43. The mean age was 62.7 years, and 78% of all patients were in New York Heart Association functional class III or IV before operation. Coronary artery bypass graft was necessary in 232 patients and replacement of ascending aorta in 55. There were 31 operative deaths (AVR, 4%; MVR, 6%; DVR, 9%). Follow-up was complete in 98.5% of the patients and extended from 12 to 103 months, with a mean of 49 months. At the last follow-up, 85% of the patients were in New York Heart Association class I or II. The actuarial survival at 8 years was 79% ± 3% for AVR, 68% ± 4% for MVR, and 65% ± 10% for DVR. The freedom from stroke at 8 years was 93% ± 2% for AVR, 83% ± 5% for MVR, and 90% ± 5% for DVR. At the end of 8 years 96% ± 1% of all patients were free from endocarditis, 92% ± 1% were free from primary tissue failure, and 89% ± 3% were free from reoperation. The actuarial freedom from valve-related death at 8 years was 98% ± 1% for AVR, 86% ± 5% for MVR, and 91% ± 6% for DVR. Hemodynamic assessment was obtained by Doppler echocardiography in all operative survivors and demonstrated satisfactorily effective valve orifices and transvalvular gradients. The clinical results obtained with the Hancock II bioprosthesis have been gratifying, particularly in the aortic position. This bioprosthesis is our biological valve of choice.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, S. Schiffelers, J. Wallrath, and G. Wahl
The Mosaic porcine bioprosthesis: Role of age on clinical performance in aortic position
J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1440 - 1448.e1.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Aziz, J. S. Lawton, H. S. Maniar, M. K. Pasque, R. J. Damiano Jr, and M. R. Moon
Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis-Patient Mismatch
Ann. Thorac. Surg., October 1, 2010; 90(4): 1202 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. David, S. Armstrong, and M. Maganti
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?
Ann. Thorac. Surg., September 1, 2010; 90(3): 775 - 781.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
N. D. Desai and G. T. Christakis
Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves
Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese
Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years
Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. R. Bridges, S. M. O'Brien, J. C. Cleveland, E. B. Savage, J. S. Gammie, F. H. Edwards, E. D. Peterson, and F. L. Grover
Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1012 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. R. Moon, M. K. Pasque, N. A. Munfakh, S. J. Melby, J. S. Lawton, N. Moazami, J. E. Codd, T. D. Crabtree, H. B. Barner, and R. J. Damiano Jr
Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival
Ann. Thorac. Surg., February 1, 2006; 81(2): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Rizzoli, T. Bottio, G. Thiene, G. Toscano, and D. Casarotto
Long-term durability of the Hancock II porcine bioprosthesis
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Bottio, G. Thiene, E. Pettenazzo, P. Ius, U. Bortolotti, G. Rizzoli, C. Valfre, D. Casarotto, and M. Valente
Hancock II bioprosthesis: A glance at the microscope in mid-long-term explants
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 99 - 105.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
N. D. Desai and G. T. Christakis
Stented Mechanical/Bioprosthetic Aortic Valve Replacement
Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Dellgren, T. E. David, E. Raanani, S. Armstrong, J. Ivanov, and H. Rakowski
Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Banbury, D. M. Cosgrove III, J. D. Thomas, E. H. Blackstone, J. Rajeswaran, J. E. Okies, and R. M. Frater
Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis
Ann. Thorac. Surg., May 1, 2002; 73(5): 1460 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. J. Fradet, N. Bleese, J. Burgess, and P. C. Cartier
Mosaic valve international clinical trial: early performance results
Ann. Thorac. Surg., May 1, 2001; 71(2007): S273 - S277.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David, J. Ivanov, S. Armstrong, C. M. Feindel, and G. Cohen
Late results of heart valve replacement with the Hancock II bioprosthesis
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0268 - 278.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Pibarot and J. G. Dumesnil
Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1131 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Wong, M. E. Legget, S. C. Greaves, B. G. Barratt-Boyes, F. P. Milsom, and P. J. Raudkivi
Early experience with the Mosaic bioprosthesis: a new generation porcine valve
Ann. Thorac. Surg., June 1, 2000; 69(6): 1846 - 1850.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. von Kodolitsch, O. Simic, A. Schwartz, C. Dresler, R. Loose, M. Staudt, J. Ostermeyer, A. Haverich, and C. A. Nienaber
Predictors of Proximal Aortic Dissection at the Time of Aortic Valve Replacement
Circulation, November 9, 1999; 100(90002): II-287 - II-294.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Cohen, T. E. David, J. Ivanov, S. Armstrong, and C. M. Feindel
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 273 - 284.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. E. Sommers and T. E. David
Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Ann. Thorac. Surg., June 1, 1997; 63(6): 1608 - 1612.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. T. Christakis, C. D. Joyner, C. D. Morgan, S. E. Fremes, K. J. Buth, J. Y. Sever, V. Rao, K. P. Panagiotopoulos, P. M. Murphy, and B. S. Goldman
Left Ventricular Mass Regression Early After Aortic Valve Replacement
Ann. Thorac. Surg., October 1, 1996; 62(4): 1084 - 1089.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, A. I. Munro, R. T. Miyagishima, P. Allen, L. H. Burr, and G. F. O. Tyers
Carpentier-edwards standard porcine bioprosthesis: Clinical performance to seventeen years
Ann. Thorac. Surg., October 1, 1995; 60(4): 999 - 1007.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Fernandez, C. Chen, J. Gu, O. B. Brdlik, G. W. Laub, M. M. Murphy, M. S. Adkins, W. A. Anderson, and L. B. McGrath
Comparison of low-pressure versus standard-pressure fixation carpentier-Edwards bioprosthesis
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S205 - S210.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. Bortolotti, A. Milano, E. Mossuto, E. Mazzaro, G. Thiene, and D. Casarotto
Porcine valve durability: A comparison between Hancock standard and Hancock II bioprostheses
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S216 - S220.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. David, S. Armstrong, and Z. Sun
The Hancock II bioprosthesis at ten years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S229 - S234.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, L. H. Burr, G. Frank, O. Tyers, R. T. Miyagishima, M. T. Janusz, H. Ling, G. J. Fradet, J. MacNab, F. Chan, et al.
Carpentier-Edwards supraannular porcine bioprosthesis: Clinical performance to twelve years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S235 - S240.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, L. H. Burr, R. T. Miyagishima, G. J. Fradet, M. T. Janusz, G. Frank, O. Tyers, J. MacNab, and F. Chan
Structural deterioration in Carpentier-Edwards standard and supraannular porcine bioprostheses
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S241 - S247.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Lemieux, W. R. Eric Jamieson, R. W. Landymore, J. G. Dumesnil, J. Metras, A. Ian Munro, G. Raymond, G. Frank, O. Tyers, P. C. Cartier, et al.
Medtronic intact porcine bioprosthesis: Clinical performance to seven years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S258 - S263.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David, C. M. Feindel, J. Bos, Z. Sun, H. E. Scully, and H. Rakowski
Aortic valve replacement with a stentless porcine aortic valveA six-year experience
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1030 - 1036.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.